年龄与病程对法国多发性硬化患者超额死亡率的影响
基于法国18个多发性硬化专家中心37,524例患者(71%女性,平均发病年龄33.0±10.6岁)的国家队列数据,采用多维惩罚样条模型分析年龄与病程对超额死亡率的动态影响。复发型MS发病后10年内无超额死亡,此后超额死亡率随当前年龄增长,70岁后各发病年龄组趋同;男性和原发性进展型MS超额死亡风险更高。
要点
- 复发型MS发病后10年内无超额死亡,之后超额死亡率随当前年龄增长。
- 当前年龄70岁后,复发型MS超额死亡率趋同,病程不再有额外影响。
- 男性复发型MS超额风险比1.46(95%CI 1.25-1.70),原发性进展型MS无性别差异。
核心结论
- 复发型MS中当前年龄对死亡率的影响强于病程,原发性进展型MS中二者作用不明确。
研究设计与样本
- 基于法国18个MS专家中心参与Observatoire Français de la Sclérose en Plaques的全国队列,纳入1960至2014年间临床发病的多发性硬化患者,随访至2016年1月1日。
- 共纳入37,524例患者(71%女性,平均发病年龄±SD 33.0±10.6岁),观察到2,883例死亡(7.7%),7.8%失访。
- 按复发型与原发性进展型MS分别建模,采用多维惩罚样条对年龄和病程的超额死亡率对数进行建模。
主要发现
- 复发型MS发病后10年内无超额死亡,此后超额死亡率随当前年龄增长,与发病年龄无关。
- 复发型MS从当前年龄70岁起,超额死亡率趋同,病程不再有影响。
- 复发型MS男性超额风险比1.46(95%CI 1.25-1.70)。
- 原发性进展型MS超额死亡率自发病起迅速上升,与发病年龄相关,但与性别无关。
临床怎么用
- 复发型MS死亡风险管理应重点关注当前年龄而非病程,尤其高龄患者。
- 男性复发型MS患者需警惕更高的超额死亡风险。
- 原发性进展型MS患者自发病起即需关注超额死亡风险,并与发病年龄相关。
局限性
- 7.8%患者失访可能影响死亡率估计的完整性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the effects of current age and disease duration on excess mortality in multiple sclerosis (MS), we describe the dynamics of excess death rates over these 2 time scales and study the effect of age at MS clinical onset on these dynamics, separately in each initial phenotype. METHODS: We used data from 18 French MS expert centers participating in the Observatoire Français de la Sclérose en Plaques. Patients with MS living in metropolitan France and having a clinical onset between 1960 and 2014 were included. Vital status was updated on January 1, 2016. For each MS phenotype separately (relapsing onset [RMS] or primary progressive [PPMS]), we used an innovative statistical method to model the logarithm of excess death rates by a multidimensional penalized spline of age and disease duration. RESULTS: Among 37,524 patients (71% women, mean age at MS onset ± SD 33.0 ± 10.6 years), 2,883 (7.7%) deaths were observed and 7.8% of patients were lost to follow-up. For patients with RMS, there was no excess mortality during the first 10 years after disease onset; afterwards, whatever the age at onset, excess death rates increased with current age. From current age 70, the excess death rate values converged and became identical whatever the age at disease onset, which means that disease duration had no more effect. Excess death rates were higher in men, with an excess hazard ratio of 1.46 (95% confidence interval 1.25-1.70). In contrast, in patients with PPMS, excess death rates rapidly increased from disease onset, and were associated with age at onset, but not with sex. CONCLUSIONS: In RMS, current age has a stronger effect on MS mortality than disease duration, while their respective effects are not clear in PPMS.
引用
- Rollot F, Fauvernier M, Uhry Z, et al. Effects of Age and Disease Duration on Excess Mortality in Patients With Multiple Sclerosis From a French Nationwide Cohort. Neurology. 2021. PMID: 34011577. doi:10.1212/WNL.0000000000012224
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。